hESCs represent an important source of cell therapies in regenerative medicine and the study of early human development. A number of hESC-based therapies are nearing clinical trials. To bring these…
Cardiovascular diseases remain the major cause of death in the western world. Stem and progenitor cell-derived cardiomyocytes (SPC-CMs) hold great promise for the myocardial repair. However, most of SPC-CMs displayed…
One of the great promises of stem cell research is that doctors will find a way to isolate and modify patient’s stem cells so that they be reinjected into patients…
The stem cell research has started making many promising discoveries already. Future clinical trials will require that the location and number of such cells be tracked in live subjects, over…
Human embryonic stem cells (hESC) are being considered for a wide range of research and therapeutic uses. Cell therapy is the most challenging of the potential clinical applications and its…
Stem cells are unique among cell types found in the human body: These cells are pluripotent; that is, they can develop into any of the more than 200 cell types…
A deeper understanding of the biological mechanisms that govern stem cells requires detailed, real-time image analysis of living cells. Currently, conventional live microscopy techniques are ineffective at imaging features like…
The rapid progress of embryonic stem cell, induced-pluripotent cell, and adult stem cell research opens the door to thousands of promising, new medical applications and discoveries. However, one of the…
There is a critical need for new technologies to facilitate growth and differentiation of human embryonic stem cells (hESC) using clinically acceptable, animal-free reagents. In particular, most currently used culture…
We are proposing to optimize and scale up a highly advanced (microfluidic) cell culture system into manufacturable form. This system will allow researchers to: Identify stem cell culture and differentiation…
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
